Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
6 Fun Urban areas For Seniors To Travel - 2ChatGPT served as "suicide coach" in man's death, lawsuit alleges
- 3Fuel Price Spike Drives Surge in Used EV Sales in Europe
- 4Artemis II astronauts will see parts of the moon no human has before. Here’s how
- 5Wolf Bites Woman in Shocking Attack at Busy Shopping Center
- Manual for Savvy Home Lighting Framework: Lights up Your Space
- Finding China: Four Urban areas for a Remarkable Excursion
- All the eclipses, supermoons, meteor showers and planets to spot in 2026
- From Specialist to Proficient Picture taker: Individual Triumphs
- Tanzania president remorseful over internet shutdown on election day
- Nigeria warns its citizens in South Africa to be cautious after march turns violent
- What to know as New York City nurses strike for a 3rd day
- Understanding Preschool Projects: Cultivating Abilities and Advancement
- Former biotech CEO sued over COVID vaccine alleged insider trading
